{"id":"https://openalex.org/W4414775889","doi":"https://doi.org/10.1002/cpt.70086","title":"Perspective of the Pharmaceuticals and Medical Devices Agency on Drug Development for Childhood Myopia","display_name":"Perspective of the Pharmaceuticals and Medical Devices Agency on Drug Development for Childhood Myopia","publication_year":2025,"publication_date":"2025-10-03","ids":{"openalex":"https://openalex.org/W4414775889","doi":"https://doi.org/10.1002/cpt.70086","pmid":"https://pubmed.ncbi.nlm.nih.gov/41039912"},"language":"en","primary_location":{"id":"doi:10.1002/cpt.70086","doi":"https://doi.org/10.1002/cpt.70086","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.70086","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.70086","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.70086","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057887804","display_name":"Mitsuru Arima","orcid":"https://orcid.org/0000-0002-6081-8133","observed_orcids":["https://orcid.org/0000-0002-6081-8133"]},"institutions":[{"id":"https://openalex.org/I91962293","display_name":"Pharmaceuticals and Medical Devices Agency","ror":"https://ror.org/03mpkb302","country_code":"JP","type":"government","lineage":["https://openalex.org/I91962293"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Mitsuru Arima","raw_affiliation_strings":["Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","institution_ids":["https://openalex.org/I91962293"]},{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan","institution_ids":["https://openalex.org/I91962293"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Motomasa Atsumi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91962293","display_name":"Pharmaceuticals and Medical Devices Agency","ror":"https://ror.org/03mpkb302","country_code":"JP","type":"government","lineage":["https://openalex.org/I91962293"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Motomasa Atsumi","raw_affiliation_strings":["Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","institution_ids":["https://openalex.org/I91962293"]},{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan","institution_ids":["https://openalex.org/I91962293"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kumiko Takeuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91962293","display_name":"Pharmaceuticals and Medical Devices Agency","ror":"https://ror.org/03mpkb302","country_code":"JP","type":"government","lineage":["https://openalex.org/I91962293"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kumiko Takeuchi","raw_affiliation_strings":["Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","institution_ids":["https://openalex.org/I91962293"]},{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan","institution_ids":["https://openalex.org/I91962293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103171782","display_name":"Takumi Aoki","orcid":"https://orcid.org/0000-0002-9788-680X","observed_orcids":["https://orcid.org/0000-0002-9788-680X"]},"institutions":[{"id":"https://openalex.org/I91962293","display_name":"Pharmaceuticals and Medical Devices Agency","ror":"https://ror.org/03mpkb302","country_code":"JP","type":"government","lineage":["https://openalex.org/I91962293"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takumi Aoki","raw_affiliation_strings":["Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","institution_ids":["https://openalex.org/I91962293"]},{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan","institution_ids":["https://openalex.org/I91962293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113657581","display_name":"Emi Inagaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91962293","display_name":"Pharmaceuticals and Medical Devices Agency","ror":"https://ror.org/03mpkb302","country_code":"JP","type":"government","lineage":["https://openalex.org/I91962293"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Emi Inagaki","raw_affiliation_strings":["Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","institution_ids":["https://openalex.org/I91962293"]},{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan","institution_ids":["https://openalex.org/I91962293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073066693","display_name":"Yosuke Kobayashi","orcid":"https://orcid.org/0000-0003-3959-4347","observed_orcids":["https://orcid.org/0000-0003-3959-4347","https://orcid.org/0009-0009-3986-9700"]},"institutions":[{"id":"https://openalex.org/I91962293","display_name":"Pharmaceuticals and Medical Devices Agency","ror":"https://ror.org/03mpkb302","country_code":"JP","type":"government","lineage":["https://openalex.org/I91962293"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yosuke Kobayashi","raw_affiliation_strings":["Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","institution_ids":["https://openalex.org/I91962293"]},{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan","institution_ids":["https://openalex.org/I91962293"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Takuya Kageyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91962293","display_name":"Pharmaceuticals and Medical Devices Agency","ror":"https://ror.org/03mpkb302","country_code":"JP","type":"government","lineage":["https://openalex.org/I91962293"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takuya Kageyama","raw_affiliation_strings":["Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","institution_ids":["https://openalex.org/I91962293"]},{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan","institution_ids":["https://openalex.org/I91962293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103449591","display_name":"Kazuki Izumi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91962293","display_name":"Pharmaceuticals and Medical Devices Agency","ror":"https://ror.org/03mpkb302","country_code":"JP","type":"government","lineage":["https://openalex.org/I91962293"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuki Izumi","raw_affiliation_strings":["Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","institution_ids":["https://openalex.org/I91962293"]},{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan","institution_ids":["https://openalex.org/I91962293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066365763","display_name":"Atsushi Yoshimura","orcid":"https://orcid.org/0000-0001-9281-9408","observed_orcids":["https://orcid.org/0000-0001-9281-9408"]},"institutions":[{"id":"https://openalex.org/I91962293","display_name":"Pharmaceuticals and Medical Devices Agency","ror":"https://ror.org/03mpkb302","country_code":"JP","type":"government","lineage":["https://openalex.org/I91962293"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atsushi Yoshimura","raw_affiliation_strings":["Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","institution_ids":["https://openalex.org/I91962293"]},{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan","institution_ids":["https://openalex.org/I91962293"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046521057","display_name":"Wataru Asakura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91962293","display_name":"Pharmaceuticals and Medical Devices Agency","ror":"https://ror.org/03mpkb302","country_code":"JP","type":"government","lineage":["https://openalex.org/I91962293"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Wataru Asakura","raw_affiliation_strings":["Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency  Tokyo Japan","institution_ids":["https://openalex.org/I91962293"]},{"raw_affiliation_string":"Office of New Drug III, Pharmaceuticals and Medical Device Agency, Tokyo, Japan","institution_ids":["https://openalex.org/I91962293"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5057887804"],"corresponding_institution_ids":["https://openalex.org/I91962293"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":{"value":4410,"currency":"USD","value_usd":4410},"fwci":1.8689,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.86905937,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":97},"biblio":{"volume":"119","issue":"1","first_page":"26","last_page":"29"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10381","display_name":"Ophthalmology and Visual Impairment Studies","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10381","display_name":"Ophthalmology and Visual Impairment Studies","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.02889999933540821,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/childhood-myopia","display_name":"childhood myopia","score":0.9269999861717224},{"id":"https://openalex.org/keywords/pathological-myopia","display_name":"pathologic myopia","score":0.8769999742507935},{"id":"https://openalex.org/keywords/myopia-progression","display_name":"myopia progression","score":0.9399999976158142},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.7450000047683716},{"id":"https://openalex.org/keywords/regulatory-assessment","display_name":"regulatory evaluation","score":0.8090000152587891},{"id":"https://openalex.org/keywords/pharmaceuticals-and-medical-devices-agency","display_name":"Pharmaceuticals and Medical Devices Agency","score":0.9089999794960022},{"id":"https://openalex.org/keywords/vision-loss","display_name":"vision loss","score":0.46299999952316284}],"concepts":[{"id":"https://openalex.org/C12713177","wikidata":"https://www.wikidata.org/wiki/Q1900281","display_name":"Perspective (graphical)","level":2,"score":0.7455999851226807},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.6650999784469604},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5534999966621399},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5088000297546387},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.4970000088214874},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45170000195503235},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.4097000062465668},{"id":"https://openalex.org/C3019398576","wikidata":"https://www.wikidata.org/wiki/Q1639780","display_name":"Regulatory agency","level":2,"score":0.3903999924659729},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.3495999872684479},{"id":"https://openalex.org/C109260823","wikidata":"https://www.wikidata.org/wiki/Q407784","display_name":"Child development","level":2,"score":0.3427000045776367},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.314300000667572},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3125},{"id":"https://openalex.org/C2992125907","wikidata":"https://www.wikidata.org/wiki/Q1741837","display_name":"Child health","level":2,"score":0.30720001459121704},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.30250000953674316},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.30149999260902405},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.2904999852180481},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.29030001163482666},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.2646999955177307},{"id":"https://openalex.org/C2988729646","wikidata":"https://www.wikidata.org/wiki/Q838129","display_name":"Process development","level":2,"score":0.25769999623298645}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D001285","descriptor_name":"Atropine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001285","descriptor_name":"Atropine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001285","descriptor_name":"Atropine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001285","descriptor_name":"Atropine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001285","descriptor_name":"Atropine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001285","descriptor_name":"Atropine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001285","descriptor_name":"Atropine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001285","descriptor_name":"Atropine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009216","descriptor_name":"Myopia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009216","descriptor_name":"Myopia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009216","descriptor_name":"Myopia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009216","descriptor_name":"Myopia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009216","descriptor_name":"Myopia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D009216","descriptor_name":"Myopia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D009216","descriptor_name":"Myopia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D009216","descriptor_name":"Myopia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/cpt.70086","doi":"https://doi.org/10.1002/cpt.70086","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.70086","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.70086","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:41039912","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41039912","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12746512","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12746512/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clin Pharmacol Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/cpt.70086","doi":"https://doi.org/10.1002/cpt.70086","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.70086","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.70086","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4414775889.pdf","grobid_xml":"https://content.openalex.org/works/W4414775889.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W2810734522","https://openalex.org/W2820431423","https://openalex.org/W2919280075","https://openalex.org/W3159823987","https://openalex.org/W4206304691","https://openalex.org/W4386739375","https://openalex.org/W4407110688"],"related_works":[],"abstract_inverted_index":{"Pathologic":[0],"myopia":[1,33],"represents":[2],"a":[3],"global":[4],"public":[5],"health":[6],"concern,":[7],"with":[8,24],"increasing":[9],"prevalence":[10],"and":[11,20,56,61],"vision":[12],"loss":[13],"risk.":[14],"Myopia":[15],"typically":[16],"develops":[17],"in":[18],"childhood":[19],"progresses":[21],"more":[22],"rapidly":[23],"earlier":[25],"onset.":[26],"Clinical":[27],"trials":[28],"exploring":[29],"treatments":[30],"for":[31,64],"decelerating":[32],"progression":[34],"are":[35],"underway.":[36],"In":[37],"Japan,":[38],"0.025%":[39],"atropine":[40],"ophthalmic":[41],"solution":[42],"(RYJUSEA\u00ae)":[43],"has":[44],"been":[45],"approved.":[46],"This":[47],"review":[48],"outlines":[49],"the":[50,54],"evaluation":[51],"process":[52],"by":[53],"Pharmaceuticals":[55],"Medical":[57],"Devices":[58],"Agency":[59],"(PMDA)":[60],"highlights":[62],"challenges":[63],"future":[65],"drug":[66],"development.":[67]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}